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Abstract
Fluorescence measurements have been used to track the dosimetry of photodynamic therapy
(PDT) for many years, and this approach can be especially important for treatments with
aminolevulinic-acid-induced protoporphyrin IX (ALA-PpIX). PpIX photobleaches rapidly, and
the bleaching is known to be oxygen dependent, and at the same time, fractionation or reduced
irradiance treatments have been shown to significantly increase efficacy. Thus, in vivo
measurement of either the bleaching rate and/or the total bleaching yield could be used to track the
deposited dose in tissue and determine the optimal treatment plans. Fluorescence in rat esophagus
and human Barrett’s esophagus are measured during PDT in both continuous and fractionated
light delivery treatment, and the bleaching is quantified. Reducing the optical irradiance from 50
to 25 mW/cm did not significantly alter photobleaching in rat esophagus, but fractionation of the
light at 1-min on and off intervals did increase photobleaching up to 10% more (p value=0.02) and
up to 25% more in the human Barrett’s tissue (p value<0.001). While two different tissues and two
different dosimetry systems are used, the data support the overall hypothesis that light
fractionation in ALA-PpIX PDT esophageal treatments should have a beneficial effect on the total
treatment effect.
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1 Introduction
Recently, 5-aminolevulinic acid (ALA) has increased in usage as a prodrug for
photosensitization, and there are promising data for its clinical use in skin and mucosally
related diseases. ALA is metabolized within tissue to form the photosensitizer (PS) molecule
protoporphyrin IX (PpIX) and partly owes its application to the selectivity with which PpIX
is formed within cancerous tissue, and also to the ease of use in topical and oral
administration of ALA itself. However, a major limiting factor in the useful application of
photodynamic therapy (PDT) with PpIX is the rapid photobleaching that is known to occur.1
In this paper, the use of ALA-PpIX-based PDT is examined with a particular focus on the
issue of how much photobleaching occurs in the course of therapy, and if the photobleaching
is affected by the method of light administration. While there are limited data on this subject
in humans, due to the limited use of dosimetry instrumentation in these treatments, it may be
possible to improve the significance of this effect by comparing the sum of pertinent data
from human and rodent measurements.
The kinetics of photobleaching are actually quite complex, as the initial decay appears to be
oxygen dependent.2 Thus, while basic cellular studies of the bleaching have provided
fundamental insight, the implementation of real in vivo dosimetry through this approach has
been a little more elusive, because of the complex dynamics between PSs and oxygen.3 It is
well known that PpIX is photobleached quickly,4,5 yet it is also well established that there is
a later phase during PDT when the bleaching rate is substantially lower than the initial rate,
which is presumably due to the absence of oxygen.1,6 The bleaching rate also appears to
have some information about the photochemical deposition, which could be exploited.
Independent of the real underlying physical chemistry, a system for real-time control of
bleaching is essential to providing some intelligent and dynamic feedback control of the
PDT process in the esophagus.
However, another confounding factor in these measurements is that the photobleaching in
vivo by fluorescence can be artifactually contaminated by a depth-dependent bleaching,
where initially there is a loss of intensity in the upper tissue layers, and fluorescence decays
at a slower rate due to detection of emission from lower tissue layers.7,8 To minimize this
effect, it has been shown that detection of the fluorescence from very small sampling fibers
can restrict this effect in the measured data.1,9–11 However, PpIX is actually only weakly
fluorescent, and it has an small Q-band absorption peak at 633 nm. When excited by visible
light, PpIX will produce fluorescence with a peak around 645 nm and with a secondary peak
near 700 nm. Figure 1 shows the spectrum of PpIX both before and after 10-J/cm2
irradiation to the solution. Measuring fluorescence from PpIX is a well-developed method
for dosimetric measurements,1,6,12–14 and in this paper, the small fiber-optic-based system
was used to produce real-time “microsampling” of photosensitizer tissue fluorescence11,15,16
in a manner that is not highly affected by the tissue optical properties.
To noninvasively measure PpIX during PDT, there are two possible ways to sample the
signal, either actively or passively during the therapy. In an active dosimeter, the probe light
is applied to the tissue, possibly with some lock-in detection approach to sampling where the
applied light dose is intermittently turned on to induce fluorescence.10,11 In passive
dosimetry, the fluorescence is directly measured during treatment illumination, recording the
emission signal continuously during the entire treatment.1 While active dosimetry has been
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approved and used in our clinical center for some time, the use of passive dosimetry has not
been, and so remains an experimental protocol. However, the use of passive dosimetry,
while technically challenging, can provide a much richer temporal data set, as values are
acquired throughout the entire treatment. Thus, here we compare active dosimetry values for
human studies with passive dosimetry values for rodent studies.
The goal of this study was predominantly to examine the available data to determine if the
photobleaching rate is affected during changes in light delivery, and if that change was
mirrored in the animal versus human data available. Eventually this information could be
useful to impact the treatment efficacy, since the rate of photobleaching.1,6 is expected to be
correlated to the treatment effect.
2 Materials and Methods
2.1 Passive Esophageal Dosimetry System
A second design for an esophageal dosimetry system was constructed, to “passively”
measure the porphyrin fluorescence (i.e., proportional to active concentration) during PDT
light treatment. The dosimeter has capability for six input fibers from six different sites of
the esophagus. In this design, the fluorescent signals excited by the treatment laser at a 635-
nm wavelength and would be acquired by the fiber tips which are attached to the treatment
balloon. The optical signals that contain porphyrin fluorescence signal (fluorescence channel
measurement) and the treatment laser signal (reference channel measurement) are separated
by a splitter and then measured by two different photomultiplier tubes (PMTs) (Fig. 2).
These signals from different sites are recorded sequentially in a rapid cycling manner.
Relative to the PpIX fluorescence spectrum excited by a 635-nm laser, two filters (620- to
650-nm bandpass filter for the reference channel and a 690-nm high-pass filter for the
fluorescence channel) are placed before the PMTs to reduce crosstalk between the two
optical channel signals and eliminate the noise.
Both the PpIX fluorescence signal and the PDT treatment laser signal were acquired by
diffused end tip fibers. The diffused end tip is 1 cm long with a diameter of 200 μm. Two
different kinds of probes were used for signal acquisition. For large animal studies (not
reported here), a balloon probe was used [Fig. 2(a)] with detection fibers attached to the
balloon membrane at up to six different positions. After the probe is inserted into the
esophagus and reaches the treatment area, the balloon probe is inflated and the detection
fibers are closely attached to the esophagus; thus, those fibers would acquire both signal
intensity and signal spatial information. For small-animal studies, a single detection fiber
was attached right beside the PDT irradiation fiber.
The detection fibers were lined to a 6-to-1 fiber coupler. Right before the coupler, six shutter
sets were introduced. Each shutter consisted of a mechanical block, two collimators, and an
aluminum holder. The shutter was controlled by Lab-VIEW to open/block the optical path
between two collimators. Each of the six input fibers of the coupler were 200 μm and the
output fiber was 800 μm, which is lined to the optical collimator [Fig. 2(c)]. By sequentially
opening and closing each shutter, the signal from six different detection fibers are sent to the
PMT via this single optical pathway.
The optical signal from the detection fiber contained both PDT treatment laser information
(around 635 nm) and PpIX fluorescence information. The photoproduct of PpIX (most likely
the result of PpIX photobleaching) yields fluorescence with a peak around 670 nm of 10-nm
bandwidth, and thus it can be challenging to separate this from the 700-nm peak of PpIX. As
illustrated in Fig. 2(b), the photons from the detection fiber hit a dichroic mirror and are
divided into two difference channels. The reference channel had a 620- to 650-nm bandpass
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filter right before the PMT. This reference channel was required to measure the PDT
treatment laser (635-nm) intensity. The fluorescence channel used a 690-nm long-pass filter
right before the PMT, to block both the excitation laser and the photoproduct fluorescence.
Two separate photomultipliers (Model HC120, Hamamatsu Inc.) were used to measure the
optical signals. The PMT gains were fixed at 0.6 and 0.8 V for reference and fluorescence
channels, respectively, as these provided a measurable range from 0 to 1.0 V. The current
signals coming from PMTs where amplified and acquired as a voltage using a standard 12-
bit data acquisition card (National Instruments DAQ 2064E) which was addressed through
LabVIEW.
2.2 Passive Dosimetry System Calibration in Liquid Phantoms
As the dosimeter system was constructed, a series of calibration studies in liquid phantoms
were designed to verify the consistency of the dosimeter, and to investigate the correlation
between the PDT treatment laser output power and reference channel signal, and also to
investigate the correlation between PpIX concentration and fluorescence channel signals.
Liquid phantoms were made up of different concentrations of Intralipid, ink, and PpIX. A
mixture of 1% Intralipid approximately equals the reduced scattering coefficient of
, with 1% of the 100:1 diluted ink solution is approximately equal to an
absorption coefficient of μa = 0.025 mm−1 at 635 nm. To simulate the measurement in
esophageal tissue, phantoms were made to approximately the same optical properties
expected in tissue, with values of  and μa = 0.04 mm−1. Liquid phantoms were
held in 15-ml plastic tubes with a total volume of 10 ml.
2.3 Animal Experiments
The Dartmouth College Animal Care and Use Committee (IACUC) approved all animal
work in this study. Sprague-Dawley rats were purchased from Charles River Laboratories
(Wilmington, Massachusetts), at 6 weeks old and housed in cages under standard laboratory
conditions (room temperature, 22±2 ° C; relative humidity, 55% ±5%; and 12-h light/dark
cycle).
The animals were a subset of a larger study with normal Sprague-Dawley rats, with a total of
28 used here. Animals were randomized into four groups and ALA was administrated at
different doses [intraperitoneal (ip) at 50 mg/kg]. After a 2-h incubation time, the rat
esophagus was irradiated with a 633-nm laser. The irradiation was delivered into the lower
esophagus through a 1 cm long diffusing tip fiber. A total of 20 J/cm linear irradiance was
delivered to each rat with different fluence rates (25 or 50 mW/cm) and different laser
irradiation methods (continuous irradiation or fractionated irradiation with a 1-min laser on/
off interval). During the treatment, rats were anaesthetized with ketamine (90 mg/kg) and
xylazine (10 mg/kg). The passive fluorescence dosimeter was used during the PDT
treatment; both local laser fluence rate and PpIX fluorescence were monitored. The initial
values and final values are used in this report.
Four PDT treatment groups were studied:
1. Group 1 (n = 8) with 50-mg/kg ALA administration dose and 20-J/cm light
irradiation at the fluence rate of 50 mW/cm (continuous treatment)
2. Group 2 (n = 5) with 50-mg/kg ALA administration dose and 20-J/cm light
irradiation at the fluence rate of 25 mW/cm (continuous treatment)
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3. Group 3 (n = 7) with 50-mg/kg ALA administration dose and 20-J/cm light
irradiation at the fluence rate of 50 mW/cm (fractionated treatment)
4. Group 4 (n = 9) with 50-mg/kg ALA administration dose and 20-J/cm light
irradiation at the fluence rate of 25 mW/cm (fractionated treatment).
The passive esophagus dosimeter was used in the esophagus beside the treatment fiber
during the PDT light delivery. This dosimeter could monitor both irradiation light fluence
rate and PpIX fluorescence. The system is illustrated in Fig. 2, however, only one detection
sensor was used in the rat esophagus study. After rats were anaesthetized, both the PDT
irradiation fiber and dosimeter detection fiber were inserted down to rat lower esophagus
together. During PDT treatment, measurements were taken every 10 s. The treatment laser
fluence rate was measured through a 620- to 650-nm bandpass filter, and the PpIX
fluorescence was measured through a 690-nm longer pass filter. The dual PMT detection of
this dosimeter was used to provide simultaneous acquisition of the signals, and correction
for laser intensity fluctuations.
2.4 Clinical Active Photosensitizer Dosimetry
While the passive dosimeter has been successfully used in animals, it is not yet approved for
human use, and therefore it is not possible to obtain continuous measurement of the
fluorescence during treatment. The clinical dosimetry system in vivo was developed and
demonstrated in previous studies.11,15,17–19 Briefly, the system uses blue light (405 nm
wavelength) excitation and very small optical fibers (100 μm core diameter) to limit the
penetration and distance traveled by light that is detected. The light that is captured from the
tissue must have originated within a few scattering distances (typically 100 to 300 μm) of
the fibers surface for significant probability of detection. This enables the signal to be
linearly proportional to the fluorophore concentration and not significantly affected by
variations in tissue optical properties.11 The original design was proposed for surface
measurements and the working end, which took measurements from the tissue, was designed
to be 6 mm across. This end consisted of a set of seven fiber bundles, each having seven
individual fibers, where the middle fiber delivered the excitation light and the surrounding
ring of six fibers collected the fluorescence. Each set of fibers was separated from each other
one by more than a millimeter to enable minimal crosstalk between them. This dosimeter
system has been used here for esophageal measurements using a smaller single fiber,
consisting of only a single set of seven fibers, with the inner fiber carrying the excitation and
the outer six fibers picking up the emission.
Sampling of the fluorescence uses approximately 1 mW of total power, and lock-in
detection with the light cycled on and off at 200 Hz. The signal is calibrated to be linearly
proportional to typical in vivo concentrations of PpIX, and normal acquisition requires about
0.5 s. Due to the light sensitivity of this instrument, it cannot be used during laser therapy,
without additional filtering optics.
This dosimetry system was produced through NCI sponsorship and three such dosimeters
are in use at the biomedical laboratories of Massachusetts General Hospital (clinical and
preclinical use), Cleveland Clinic (clinical and preclinical use), and Dartmouth Hitchcock
Medical Center (preclinical use only). Due to the fact that the treatment beam must be
turned off during acquisition, there are fluorescence data only for before and after therapy
for clinical studies.
2.5 Clinical PDT Treatment and Fluorescence Dosimetry
Human studies were carried out at the Massachusetts General Hospital under an Institutional
Review Board (IRB)-approved protocol for Barrett’s esophagus PDT. Six subjects were
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recruited into this arm of the study and baseline fluorescence measurements of the buccal
mucosa were taken using the active fluorescence dosimeter. Patients were then given a
solution of ALA in orange juice to take orally (30 mg/kg ALA by body weight). Following a
4-h incubation period, patients received topical anesthesia to numb the pharynx as well as
intravenous sedation. Pre-PDT irradiation measurements of PpIX levels were taken of the
Barrett’s tissue and surrounding normal sites using the fluorescence dosimeter.
Postirradiation measurements were taken of the treated sites with the Aurora to measure
PpIX levels. Biopsy samples of the diseased and normal tissue were also obtained at the pre-
and posttreatment times.
A 5-mm diffusing optical fiber nested in a cylindrical balloon dilator (Fig. 1) was then used
to deliver 635-nm light from a KTP/YAG XP 800 dye laser (Laserscope, San Jose,
California) to the esophageal lumen. The 5-mm radially diffusing optical fiber was placed
within an 18-mm-diam clear cylindrical balloon dilator, so that the fiber was at the center of
the esophageal lumen, providing even distribution of the light to the esophageal lumen. A
total fluence of 150 J/cm2, at a tissue surface irradiance of 150 mW/cm2, was delivered
either continuously or as a fractionated dose (60-s light/dark intervals).
The fluorescence dosimeter was used to measure PpIX fluorescence levels in the patient
tissue. A 405-nm diode laser provides the excitation light to a fiber optic bundle composed
of one excitation fiber surrounded by six fluorescence emission collection fibers with a total
diameter of 0.1 in. at the distal tip.
2.6 Statistical Analysis
In all analyses of fluorescence changes examined here, a one-tailed t test was used, with
two-sample unequal variance. The differences in fluorescence pre- and posttreatment were
mainly examined for differences, to determine if photobleaching was significant.
3 Results
3.1 Passive Dosimeter Calibration and Correction for Crosstalk
A total of three sets of liquid phantoms were made with  and μa = 0.04 mm−1,
but no PpIX was added in phantoms. The detection fiber was inserted into the center of the
liquid. Laser outputs were set at 0, 14, 21, 32, 67, 128, and 165 mW/cm, and measurements
were taken at each of these levels.
As illustrated in Fig. 3(a), the reference channel PMT output signals (voltage) had linear
correlation with laser outputs. Since 25, 50, and 100 mW/cm are the most used laser powers
for ALA-PpIX PDT treatment in the esophagus, our phantom study demonstrated a reliable
laser dosimeter in our system. The reading from the reference channel PMT could be used to
calculate the PDT light dose.
From the light dosimeter calibration phantom study, it was also noticed that even without
any PpIX inside the phantoms, there still were some readings from the fluorescence channel
PMT. This was concluded to be crosstalk from the irradiation laser, assuming the 690 longer
pass filter could not block all photons in the range of 620 to 690 nm. To investigate the
crosstalk between reference channel and fluorescence channel, a new set of phantom studies
was designed.
A total of four sets of phantoms were made. Considering that there could be some optical
variations in individual targets, absorption coefficient μa was different in each phantom (μa
= 0.0125, 0.025, 0.04, and 0.05 mm−1). Reduced scattering coefficient  was still set at 1.1
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mm−1 for all phantoms and no PpIX was added into the phantoms. Laser outputs were set at
32, 67, and 128 mW/cm, and measurements were taken at each of these settings.
As seen in Fig. 3(b), the results showed that the crosstalk from the reference channel was
linearly increasing with the laser output, yet the crosstalk was also very consistent as the
optical properties varied within the pertinent range of possible values. These data were fitted
into a linear function y = kx + b, where the reference channel (x) to fluorescence channel (y)
crosstalk functions were y = 0.108x + 0.068 (μa = 0.0125 mm−1), y = 0.110x + 0.062 (μa =
0.025 mm−1), y = 0.112x + 0.060 (μa = 0.04 mm−1), and y = 0.118x + 0.059 (μa = 0.05
mm−1), respectively. The slope rate k had 3.8% variation, while b has 6% variation,
indicating that these calibration lines could work for a broad range of tissue optical
properties. With this consistent linear crosstalk function, readings from the fluorescence
channel could be adjusted according to reference channel readings and the crosstalk could be
effectively corrected for.
To investigate the correlation between detected fluorescence signal and the actual PpIX
concentration, eight sets of liquid phantoms were made with same optical properties ( and μa
= 0.04 mm−1). A total of eight different concentrations of PpIX were added
into phantoms (0, 0.1, 0.2, 0.3, 0.5, 1.0, 2.0, and 3.0 μg/ml, respectively). Irradiation laser
output was set at 50 mW/cm and six measurements were taken for each phantom.
The readings are illustrated in Fig. 3(c), with the fluorescence showing positive correlation
with PpIX concentration, while the reference channel readings did not. Reference channel
readings varied ±4% and decreased a little while the PpIX concentration (fluorescence
intensity) increasing significantly. This minor decrease of reference channel signal was
reasonable with the assumption that the PpIX would affect the phantom absorption
coefficient somewhat. From the consistency of the reference channel readings, it was
assumed that the crosstalk from the fluorescence channel to the reference channel was a
minor factor. Only crosstalk from reference channel to fluorescence channel must be
addressed.
Using the measured crosstalk function, y = 0.112x + 0.060, to adjust the fluorescence
channel readings for this minor correlation, the corrected results are shown in Fig. 3(d). A
linear relationship between the fluorescence channel signal (after crosstalk adjustment) and
the PpIX concentrations was observed. It was encouraging that this passive dosimetry
system could detect down to a 0.1-μg/ml difference in the PpIX concentrations, while the
linear range included from 0 to 4.0 μg/ml, which was also the in vivo PpIX concentration
range expected in tissue.
3.2 Animal Data
The full fluorescence kinetic change was examined in detail in a previous study, but here the
focus is on the initial versus final fluorescence intensity values. There was a change in signal
level from all animals studied in this work, and the average values for each treatment group
are shown in Fig. 4(a). This illustrates the fluorescence signal in esophagus, for a fixed ALA
ip administration dose of 50 mg/kg, with a 2-h incubation time. The fluorescence intensity
changes were 15±2, 10±3, 25±3, and 21±4, respectively, for the 50-mW/cm continuous
group, the 25-mW continuous group, the 50-mW/cm fractionated group, and the 25-mW/cm
fractionated group. Interestingly, the lower fluence rates did not cause less photobleaching
than the higher ones, based on a one-tailed t test analysis of the average data. However, the
light fractionation groups both had significant increases in the photobleaching, with p values
of 0.02 and 0.016 for the 50- and the 25-mW/cm groups, respectively.
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Relative to post-ALA, pre-PDT fluorescence measurements, a significant decrease in PpIX
fluorescence levels was observed in Barrett’s tissue that received either continuous
illumination (49% ±5 %) versus the fractionated illumination (74% ±12%) (Fig. 5). The
fractionated illumination caused significantly more photobleaching than continuous
illumination (p value <0.001). PpIX fluorescence levels did not change in the oral cavity and
normal squamous control sites, as might be expected, since these areas were not irradiated
with light. However, measurement of these tissues provides a simple internal control
measurement for each subject. Biopsies of the Barrett’s tissue taken 4 h after administration
of ALA, just before treatment with light, showed a heterogeneous distribution of PpIX
fluorescence in the metaplastic tissue as confirmed by histology in a parallel tissue section
(Fig. 6).
4 Discussion
As expected during PDT, the fluorescence signal from the rat esophagus decreased in all
cases, and the effect was greatest in the fractionated delivery cases, confirming previous
reports of a greater photobleaching effect when the treatment delivery was lengthened. The
increase in photobleaching was subtle in the case of rodent data (approximate 10% increase
in bleaching), and more pronounced in the human data (approximate 25% increase in
bleaching). Interestingly in the case of 25-versus 50-mW/cm linear irradiance change, the
amount bleached did not significantly change, indicating that likely even lower linear
irradiances might be required to increase this effect. However, the inconsistency between the
effect observed with fractionation versus the effect not observed with decreased irradiance is
difficult to fully understand. It is possible that some biological or biochemical effects occur
in response to the light-off fractions, which are not present when continuous lower
irradiance illumination is used. While treatment effect could not be objectively evaluated in
the patient studies, the rodent work in this paper, combined with the previous study, would
indicate that greater photobleaching corresponds to more damage to the tissue, and hence a
superior treatment effect.
The two dosimetry systems were used without difficulty, and with sufficient dynamic range
to make them useful for routine dosimetry in clinical situations. The dosimetry could
actually be carried out with both active and passive measurement if need be. The main
technological requirement is simply working out the logistics of how to attach the fibers to
the exterior of the treatment balloon. In prototype studies, this was done reasonably well
with RTV-based glue, and several device manufacturers have potential solutions for this
type of delicate attachment. The performance of the two dosimeters in terms of SNR and
repeatability were not directly compared here, but have quite different issues in terms of use.
The active dosimeter used blue light, so the issues of crosstalk were considerably less in that
system, because the optical filtering of blue light from the emission red light is efficient and
provides a strong signal. The passive dosimeter must rely on the treatment light for
excitation and therefore uses red excitation and red-to-near-IR emission, and the crosstalk in
this type of system is inevitable. The calibration procedure used for minimization of the
crosstalk was efficient for our purposes and led to a repeatable signal with low enough
detection efficiency. Both systems were sensitive enough to be used in physiologically
known values of ALA-induced PpIX, but the active dosimeter can likely be optimized for
better sensitivity, because of the blue excitation yielding significantly higher fluorescence,
and the better ability to filter the excitation from emission light. However, a direct
comparison of the two was not done here.
There was not a significant difference in the treatment plan between the two PDT studies of
humans and rodents, since the light doses were similar. However, a weakness in the
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comparison done here is that the measurement in the human system was done with a blue-
light-based dosimeter, whereas the measurement in the rodent was done with the red-
treatment-light-based dosimeter. It is likely that the upper layers of the esophagus mucosa
bleach more quickly, and this decay is more readily observed with a blue-light-based
dosimeter. The red-light-generated signal would have a signal from a deeper mixture of
depths. Alternatively, it is possible that the human tissue had greater oxygenation and blood
supply, enabling it to be more effectively bleached away, but this hypothesis remains to be
tested fully. Future work could focus on a more mechanistic study of photobleaching with
the two types of systems, and examine the bleaching in the layers of the esophagus.
Unfortunately, the experiment is very difficult, if not impossible, to do in the human case
where the esophagus thickness and complexity is greatest.
Conclusions
The two dosimetry systems used here for esophageal measurements worked, and appeared to
give similar trends in their data in terms of fluorescence signals and photobleaching in
response to therapy. The use of reduced linear irradiance in the esophagus from 50 to 25
mW/cm did not have a significant effect on the photobleaching yield in the rodent model.
However, light fractionation on and off at 1-min intervals had a significant photobleaching
effect in both the rodent normal esophagus and the human Barrett’s esophagus treatments.
The increased photobleaching is generally thought to be indicative of a more complete
treatment, since it is oxygen dependent, and past studies have shown that the integrated
fluorescence during the photobleaching phase is linearly related to the damage done in the
tissue. Further studies could focus on either combinations of dosimetry with both blue and
red light to take measurements or more mechanistic studies to quantify the bleaching in
different.
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Emission spectrum (excited at 635 nm) of PpIX in saline. The solid lines are the PpIX
spectrum before PDT irradiation. Dashed lines are fluorescence [which likely includes
photoproduct(s) from the PpIX molecular photobleaching] spectrum after 10-J/cm2 PDT
irradiation. The PpIX photobleaching product is known to have a fluorescence peak around
670 nm, while PpIX itself has a fluorescence peak around 700 nm.
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Dosimetry system structure is outlined in (a), including a brief illustration of the fiber
excitation at 635 nm and the way to split the signal of the detection fibers into 690 long-pass
and 620 to 650 bandpass, enabling simultaneous detection and rationing. (b) and (c) The key
hardware components of the dosimetry system, including the 6-to-1 optical switch (b), PMT
detector [lower-left in (b)], electronic control board [lower-middle in (b)], and the DAQ
(data acquisition) card (lower-right). PpIX has a fluorescence peak around 700 nm, and the
peaks at 660 and 680 are thought to be photoproducts whose signal, and so emission, is
collected through a 690-nm long-pass filter. The detection part includes two PMTs for the
optical signals of excitation light and PpIX fluorescence.
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(a) Correlation of the reference channel signal to the laser output, as measured in a liquid
phantom with linear irradiances of 0 to 165 mW/cm; (b) crosstalk from the reference
channel to the fluorescence channel shown from a set of phantoms (fixed transport scattering
) with different absorption coefficient values, μa = 0.0125, 0.025, 0.04, and
0.05 mm−1; (c) fluorescence and reference channel PMT readings (red crosses=reference,
blue dots=fluorescence) for increasing concentrations of PpIX in a phantom; and (d)
correlation of fluorescence channel signals to PpIX concentrations, after crosstalk
adjustment. The detection precision was estimated to be 0.1 μg/ml, and the linear range was
up to 4 μg/ml.(Color online only.)
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(a) PpIX fluorescence as measured from rat esophagus under varying treatment conditions
before and after PDT, with error bars showing the standard error in the groups, and (b) the
calculated percentage change in the esophagus fluorescence.
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PpIX fluorescence as measured from Barrett’s tissue and two nonilluminated control sites of
oral cavity and normal squamous tissue, with standard error values in each group shown as
error bars. (a) Data from continuous irradiation (b) and fractionated irradiation with 1-min
on/off fractions. (c) Significant photobleaching was observed in the Barrett’s tissue for both
continuous illumination (P <0.001) and fractionated illumination (P <0.001) with the 635-
nm light (150 J/cm2 at 150 mW/cm2). The Barrett’s site treated with fractionated
illumination photobleached significantly more than the site treated with continuous
illumination following PDT (P <0.001).
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PpIX fluorescence levels shown as measured from Barrett’s tissue and two nonilluminated
control sites of oral cavity and normal squamous tissue. Significant photobleaching was
observed in the Barrett’s tissue following either (a) continuous illumination (P value <0.001,
n = 4) or (b) fractionated illumination (P <0.001, n = 3) with 635-nm light (150 J/cm2 at 150
mW/cm2). The Barrett’s site treated with fractionated illumination photobleached
significantly more than the site treated with continuous illumination following PDT (P value
<0.001).
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